In glioblastoma, CLOCK and its heterodimeric chaperone BMAL1 behave as tumor-promoting factors, directly modulating the NF-κB pathway, thereby regulating glioma cell migration and proliferation, and maintaining GSC stemness. The gene discussed is BMAL1; the disease is central nervous system cancer.